Appointments at Sanofi-Aventis, RXi Pharmaceuticals and Vivus – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi-Aventis, RXi Pharmaceuticals and Vivus.
Archives for November 10, 2009
Genmab selling plant and turning to CMOs
Genmab has put its Brooklyn Park, Minnesota, US facility up for sale, which will reduce its headcount by 300, and plans to use CMOs to cover for the loss of capacity.
Six Pfizer-Wyeth R&D sites to close post merger
Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.
Seventh Wave and TNO announce GI modelling pact at AAPS
Seventh Wave Laboratories will apply gastrointestinal modelling to the analysis of early stage drug candidates being developed by its customers.
Biovail highlights contract biostats offering at AAPS
Canada’s Biovail Contract Research says its stand-alone biostatistics unit will help sponsors “anticipate roadblocks ahead of time and create a sound statistical analysis plan for optimal results.”
AAPS - round up of day one
Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points.
Dow launches low aldehyde PEG
Dow has used AAPS 2009 to launch low aldehyde grades of its Carbowax Sentry PEG, which are niche products aimed at formulators seeking to improve shelf life.